Invesco
BLFS icon

Invesco’s BioLife Solutions BLFS Stock Holding History

Invesco’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44.8M Sell
2,348,532
-1,583,659
-40% -$35M ﹤0.01% 1113
2025
Q4 		$95.1M Buy
3,932,191
+332,747
+9% +$8.71M 0.01% 845
2025
Q3 		$91.8M Buy
3,599,444
+18,666
+0.5% +$443K 0.01% 860
2025
Q2 		$77.1M Buy
3,580,778
+29,724
+0.8% +$670K 0.01% 895
2025
Q1 		$81.1M Buy
3,551,054
+311,585
+10% +$8.21M 0.02% 861
2024
Q4 		$84.1M Buy
3,239,469
+36,176
+1% +$900K 0.02% 859
2024
Q3 		$80.2M Sell
3,203,293
-116,838
-4% -$2.76M 0.02% 869
2024
Q2 		$71.2M Buy
3,320,131
+2,044,714
+160% +$39.7M 0.02% 879
2024
Q1 		$23.7M Buy
1,275,417
+91,858
+8% +$1.61M 0.01% 1363
2023
Q4 		$19.2M Buy
1,183,559
+131,494
+12% +$1.68M ﹤0.01% 1428
2023
Q3 		$14.5M Buy
1,052,065
+64,475
+7% +$1.02M ﹤0.01% 1520
2023
Q2 		$21.8M Buy
987,590
+179,950
+22% +$3.79M 0.01% 1320
2023
Q1 		$17.6M Buy
807,640
+8,484
+1% +$191K ﹤0.01% 1415
2022
Q4 		$14.5M Buy
799,156
+26,548
+3% +$548K ﹤0.01% 1564
2022
Q3 		$17.6M Buy
772,608
+16,687
+2% +$357K 0.01% 1407
2022
Q2 		$10.4M Sell
755,921
-4,568
-0.6% -$67K ﹤0.01% 1821
2022
Q1 		$17.3M Sell
760,489
-9,247
-1% -$243K ﹤0.01% 1607
2021
Q4 		$28.7M Buy
769,736
+163,176
+27% +$7M 0.01% 1319
2021
Q3 		$25.7M Buy
606,560
+112,099
+23% +$5.4M 0.01% 1407
2021
Q2 		$22M Buy
494,461
+74,816
+18% +$2.64M 0.01% 1550
2021
Q1 		$15.1M Buy
419,645
+278,914
+198% +$11M ﹤0.01% 1714
2020
Q4 		$5.61M Sell
140,731
-11,280
-7% -$385K ﹤0.01% 2121
2020
Q3 		$4.4M Buy
+152,011
New +$3.28M ﹤0.01% 2070
2019
Q4 		– Sell
-10,338
Closed -$172K – 3656
2019
Q3 		$172K Sell
10,338
-70,981
-87% -$1.33M ﹤0.01% 3573
2019
Q2 		$1.38M Buy
81,319
+3,669
+5% +$64K ﹤0.01% 2887
2019
Q1 		$1.39M Buy
77,650
+51,781
+200% +$824K ﹤0.01% 2836
2018
Q4 		$311K Sell
25,869
-7,648
-23% -$91.3K ﹤0.01% 3457
2018
Q3 		$587K Buy
33,517
+6,609
+25% +$131K ﹤0.01% 3364
2018
Q2 		$307K Buy
+26,908
New +$245K ﹤0.01% 3589

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco's BLFS Position: Q1 2026 in Review

Invesco reduced its BioLife Solutions (BLFS) stake by 40% in Q1 2026, selling an estimated $35M and leaving 2,348,532 shares worth $44.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1113.

Invesco first reported a position in BLFS in Q2 2018 and has held it in 29 quarters since. The position peaked at $95.1M in Q4 2025. 187 funds tracked by Wall St. Rank hold BLFS as of Q1 2026.

  • Invesco held 2,348,532 shares of BioLife Solutions worth $44.8M as of Q1 2026.
  • Invesco sold 1,583,659 BioLife Solutions shares in Q1 2026, an estimated $35M.
  • BioLife Solutions made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #1113 holding.
  • Invesco first reported a position in BioLife Solutions in Q2 2018 and has held it in 29 quarters since.
  • Invesco's BioLife Solutions position peaked at $95.1M in Q4 2025.
  • 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.